Pulse Explorar nav.journalClub Debates Tendencias Investigadores Revistas

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology | Synapse

March 11, 2024Open Access

Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology

JTJoseph TherriaultMontreal Neurological Institute and Hospital NANicholas J. AshtonAlzheimer's Association IPIlaria PolaUniversity of Gothenburg

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This research is supported by the Weston Brain Institute, Canadian Institutes of Health Research (CIHR), Canadian Consortium on Neurodegeneration in Aging, the Alzheimer's Association, Brain Canada Foundation, the Fonds de Recherche du Québec - Santé and the Colin J. Adair Charitable Foundation.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Therriault et al. (Mon,) studied this question.

synapsesocial.com/papers/69dcc732a5c75be4cfe5423d https://doi.org/https://doi.org/10.1016/j.ebiom.2024.105046

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Aducanumab: Appropriate Use Recommendations2021 · 20 citations
2Donanemab in Early Alzheimer’s Disease2021 · 1,721 citations
3Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders2020 · 1,583 citations
4Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies2023 · 118 citations
5Blood biomarkers for Alzheimer’s disease in clinical practice and trials2023 · 487 citations